Analysed ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) News Sources
Merck Says FDA Grants Priority Review to Keytruda-Padcev Combo for Bladder Cancer
20-04-2026
yahoo.com
U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
20-04-2026
yahoo.com
Dyno Therapeutics Announces Capsid License Exercised by Astellas for Skeletal Muscle-Targeted Gene Delivery, Validating AI-Powered Technology for Biological Sequence Design
08-04-2026
yahoo.com
Pfizer aims for wider use of PARP drug in prostate cancer with new data
19-03-2026
biopharmadive.com
What is the current price of ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS)?
The current price of ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) is $15.66.
ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) since the previous trading day is $-0.52.
ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) since the previous trading day is -3.2138%.
What is the most recent average sentiment score for ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS)?
The most recent average sentiment score for ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) is 67 out of 100.
What is the most recent average sentiment for ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS)?
The most recent sentiment for ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS) is .
SEC-8K** Filing Available For ASTELLAS PHARMA INC-UNSP ADR (ALPMY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.